5-HT.sub.3 receptor antagonists for the treatment of autism
US5225407A · kind A · utility
44Cited by
3References
11Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Sep 8, 1992 |
| Grant date | Jul 6, 1993 |
| Priority date | — |
| Expiry date | Sep 8, 2012 |
Classification
- Technology area (CPC A)Human Necessities
- CPC primaryA61K31/46
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
The invention relates to the use of a compound which acts as an antagonist of 5-HT at 5-HT.sub.3 receptors in the treatment of autism or another disorder originating in childhood in which there is mental retardation.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.